New York State Common Retirement Fund’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.3M Buy
350,414
+108,561
+45% +$8.57M 0.04% 351
2025
Q4
$19.1M Buy
241,853
+73,631
+44% +$5.54M 0.03% 443
2025
Q3
$11M Buy
168,222
+81,250
+93% +$3.97M 0.01% 710
2025
Q2
$3.44M Buy
86,972
+8,711
+11% +$285K ﹤0.01% 1215
2025
Q1
$2.36M Sell
78,261
-6,000
-7% -$196K ﹤0.01% 1316
2024
Q4
$2.95M Sell
84,261
-114,498
-58% -$4.28M ﹤0.01% 1282
2024
Q3
$7.96M Sell
198,759
-16,957
-8% -$789K 0.01% 888
2024
Q2
$10.3M Buy
215,716
+83,006
+63% +$3.4M 0.01% 791
2024
Q1
$5.75M Buy
132,710
+27,381
+26% +$1.31M 0.01% 1060
2023
Q4
$5.33M Sell
105,329
-12,900
-11% -$618K 0.01% 1091
2023
Q3
$5.36M Sell
118,229
-17,327
-13% -$715K 0.01% 1080
2023
Q2
$5.56M Buy
135,556
+1,556
+1% +$59.8K 0.01% 1119
2023
Q1
$4.79M Sell
134,000
-6,500
-5% -$244K 0.01% 1184
2022
Q4
$5.31M Sell
140,500
-2,400
-2% -$101K 0.01% 1155
2022
Q3
$6.32M Sell
142,900
-3,925
-3% -$165K 0.01% 1056
2022
Q2
$5.43M Buy
146,825
+25
+0% +$943 0.01% 1158
2022
Q1
$5.44M Sell
146,800
-7,000
-5% -$229K 0.01% 1243
2021
Q4
$4.68M Sell
153,800
-87,359
-36% -$2.75M ﹤0.01% 1331
2021
Q3
$8.09M Hold
241,159
0.01% 1097
2021
Q2
$9.62M Buy
241,159
+42,928
+22% +$1.68M 0.01% 1030
2021
Q1
$8.91M Sell
198,231
-25,500
-11% -$1.42M 0.01% 1011
2020
Q4
$12.7M Sell
223,731
-12,800
-5% -$638K 0.01% 825
2020
Q3
$11.2M Sell
236,531
-22,100
-9% -$1.23M 0.01% 795
2020
Q2
$15.2M Sell
258,631
-12,900
-5% -$718K 0.02% 692
2020
Q1
$12.8M Buy
271,531
+2,773
+1% +$155K 0.02% 687
2019
Q4
$16.2M Sell
268,758
-2,915
-1% -$174K 0.02% 752
2019
Q3
$16.3M Sell
271,673
-26,843
-9% -$1.75M 0.02% 731
2019
Q2
$19.2M Buy
298,516
+893
+0.3% +$63.1K 0.02% 675
2019
Q1
$24.2M Buy
297,623
+51,775
+21% +$3.34M 0.03% 562
2018
Q4
$13.3M Sell
245,848
-48,813
-17% -$2.49M 0.02% 771
2018
Q3
$15.2M Sell
294,661
-63,839
-18% -$3M 0.02% 813
2018
Q2
$14.9M Sell
358,500
-19,500
-5% -$864K 0.02% 826
2018
Q1
$16.7M Sell
378,000
-8,000
-2% -$406K 0.02% 762
2017
Q4
$19.4M Sell
386,000
-1,492
-0.4% -$81.8K 0.02% 709
2017
Q3
$19.6M Buy
387,492
+4,000
+1% +$210K 0.03% 650
2017
Q2
$19.5M Sell
383,492
-2,761
-0.7% -$129K 0.03% 637
2017
Q1
$15.5M Buy
386,253
+1
+0% +$45 0.02% 763
2016
Q4
$18.5M Hold
386,252
0.03% 655
2016
Q3
$14.2M Sell
386,252
-24,100
-6% -$754K 0.02% 751
2016
Q2
$9.56M Sell
410,352
-1,106
-0.3% -$35.7K 0.01% 957
2016
Q1
$16.7M Buy
411,458
+6,407
+2% +$260K 0.03% 670
2015
Q4
$25.1M Sell
405,051
-49,480
-11% -$2.67M 0.04% 506
2015
Q3
$18.4M Buy
454,531
+79,979
+21% +$4.14M 0.03% 615
2015
Q2
$21.6M Buy
374,552
+213,008
+132% +$13.5M 0.03% 568
2015
Q1
$10.3M Sell
161,544
-78,343
-33% -$5.32M 0.02% 862
2014
Q4
$14.8M Sell
239,887
-86,261
-26% -$4.26M 0.02% 694
2014
Q3
$12.7M Buy
326,148
+12,415
+4% +$440K 0.02% 785
2014
Q2
$10.8M Buy
313,733
+58,039
+23% +$1.83M 0.02% 907
2014
Q1
$11M Sell
255,694
-47,798
-16% -$2.32M 0.02% 881
2013
Q4
$12.1M Buy
303,492
+124,892
+70% +$4.45M 0.02% 834
2013
Q3
$6.71M Buy
+178,600
New +$5.34M 0.01% 1044

Other funds holding IONS

New York State Common Retirement Fund's IONS Position: Q1 2026 in Review

New York State Common Retirement Fund increased its Ionis Pharmaceuticals (IONS) stake by 45% in Q1 2026, buying an estimated $8.57M and bringing the position to 350,414 shares worth $26.3M. The position accounts for 0.04% of the portfolio, ranked #351.

New York State Common Retirement Fund first reported a position in IONS in Q3 2013 and has held it in 51 quarters since. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • New York State Common Retirement Fund held 350,414 shares of Ionis Pharmaceuticals worth $26.3M as of Q1 2026.
  • New York State Common Retirement Fund bought 108,561 Ionis Pharmaceuticals shares in Q1 2026, an estimated $8.57M.
  • Ionis Pharmaceuticals made up 0.04% of New York State Common Retirement Fund's portfolio in Q1 2026, its #351 holding.
  • New York State Common Retirement Fund first reported a position in Ionis Pharmaceuticals in Q3 2013 and has held it in 51 quarters since.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on New York State Common Retirement Fund's 13F filing for Q1 2026, filed 6 May 2026.